Cytosorbents Cor (CTSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,327 | -2,829 | -975 | -4,678 | -4,009 |
| Depreciation Amortization | 269 | 209 | 102 | 376 | 276 |
| Accounts receivable | -112 | 123 | 126 | -401 | -142 |
| Other Working Capital | -256 | 138 | 241 | 291 | 980 |
| Other Operating Activity | 238 | 99 | -294 | 924 | 508 |
| Operating Cash Flow | $-4,189 | $-2,261 | $-800 | $-3,489 | $-2,387 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -7,347 | -4,745 | -4,745 | N/A | 0 |
| PPE Investments | -90 | -55 | -21 | -39 | -33 |
| Purchase Sale Intangibles | -90 | -62 | -5 | -178 | -19 |
| Other Investing Activity | -90 | -62 | -5 | -178 | -19 |
| Investing Cash Flow | $-7,526 | $-4,862 | $-4,771 | $-216 | $-52 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 1,843 | 1,263 |
| Common Stock Issued | 9,842 | 9,813 | 52 | 160 | 160 |
| Other Financing Activity | 0 | 0 | 9,751 | 2,200 | 1,600 |
| Financing Cash Flow | $9,842 | $9,813 | $9,803 | $4,203 | $3,023 |
| Exchange Rate Effect | 123 | 5 | 1 | -43 | 37 |
| Beginning Cash Position | 2,183 | 2,183 | 2,183 | 1,729 | 1,729 |
| End Cash Position | 433 | 4,878 | 6,416 | 2,183 | 2,350 |
| Net Cash Flow | $-1,750 | $2,695 | $4,233 | $454 | $621 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,189 | -2,261 | -800 | -3,489 | -2,387 |
| Capital Expenditure | -90 | -55 | -21 | -39 | -33 |
| Free Cash Flow | -4,278 | -2,316 | -822 | -3,528 | -2,420 |